ran-2 Antibody

What is RAN-2 Antibody and what cell surface antigen does it target?

RAN-2 Antibody is a monoclonal IgG2 antibody that specifically targets rat neural antigen-2 (RAN-2), a cell surface antigen primarily found on rat astrocytes and select neural cells. This antibody was originally developed by immunizing mice with enriched populations of cultured rat astrocytes, then fusing their spleen cells with NS-1 myeloma cells to create antibody-secreting hybridomas. Through extensive characterization, RAN-2 Antibody has been shown to recognize a protease-sensitive, rat-specific surface antigen .

The antibody was developed through a systematic approach to generate specific markers for neural cell types. When tested in indirect immunofluorescence assays, RAN-2 Antibody demonstrates consistent binding to its target antigen, making it a valuable tool for neural cell identification and isolation in rat model systems .

Which neural cell populations are recognized by RAN-2 Antibody?

RAN-2 Antibody exhibits a specific binding profile across rat neural cell types:

This selective binding profile makes RAN-2 Antibody particularly useful for distinguishing astrocytes and specific glial cell types in mixed neural cell populations during immunocytochemical and immunohistochemical studies .

What are the key biochemical properties of the RAN-2 antigen?

The RAN-2 antigen has several distinctive properties that influence experimental design considerations when working with RAN-2 Antibody:

• Protein composition: The antigen is protease-sensitive, indicating it contains essential protein components that are required for antibody recognition .

• Species specificity: RAN-2 is strictly rat-specific, with no cross-reactivity observed in neural tissues from other species, limiting its application to rat models .

• Cellular localization: As a cell surface marker, RAN-2 is accessible to antibody binding without cell permeabilization, enabling live-cell applications .

• Cell-type distribution: The antigen shows a distinctive pattern of expression across neural cell types, being present on astrocytes, ependymal cells, retinal Müller cells, and leptomeningeal cells, but absent from neurons, oligodendrocytes, Schwann cells, microglia, and non-neural cells .

These characteristics make RAN-2 antigen valuable for identifying specific neural cell populations in rat models, particularly when developing astrocyte isolation protocols or performing immunohistochemical analysis of rat neural tissues .

How should RAN-2 Antibody be optimized for immunohistochemistry applications?

Optimizing RAN-2 Antibody for immunohistochemistry requires careful attention to several methodological variables:

Tissue Preparation Protocol:

• Fixation: Use mild fixation (2-4% paraformaldehyde, 4-24 hours) to preserve the protease-sensitive RAN-2 antigen .

• Sectioning: For frozen sections, optimal thickness is 10-20 μm; paraffin sections may require additional antigen retrieval.

• Storage: If storing sections, maintain at -80°C with cryoprotectant to preserve antigenicity.

Staining Protocol Optimization:

• Blocking: Use 5-10% normal serum (from secondary antibody species) with 0.1-0.3% Triton X-100 for 1-2 hours at room temperature.

• Primary antibody: Test dilutions between 1:100-1:500; incubate overnight at 4°C.

• Secondary antibody: Use species-appropriate secondary at 1:200-1:1000; incubate 1-2 hours at room temperature.

• Washing: Perform 3-5 washes with PBS between each step, 5-10 minutes each.

• Counterstaining: Consider DAPI for nuclear visualization without interfering with RAN-2 signal.

Critical Quality Controls:

• Omit primary antibody to assess secondary antibody specificity

• Include known positive tissue (rat astrocyte cultures or brain sections)

• Include known negative tissue (non-rat species sections or rat neurons)

For consistent results, standardize all protocol parameters and document specific lot numbers of antibodies used across experiments.

What protocols are recommended for using RAN-2 Antibody in astrocyte isolation and purification?

RAN-2 Antibody can be employed in several complementary approaches for astrocyte isolation:

Immunopanning Protocol:

• Coat sterile petri dishes with anti-mouse IgG secondary antibody (10 μg/ml) overnight at 4°C

• Wash dishes 3× with PBS

• Apply RAN-2 Antibody (5-10 μg/ml) for 2 hours at room temperature

• Prepare single-cell suspension from rat neural tissue using papain digestion

• Incubate cell suspension on antibody-coated dishes for 30-45 minutes at 37°C

• Wash away unbound cells with gentle PBS rinses

• Either culture cells directly on plates or detach using enzyme-free cell dissociation buffer

• Expected yield: 95-97% purity of RAN-2-positive cells

Magnetic-Activated Cell Sorting (MACS) Protocol:

• Prepare single-cell suspension from rat neural tissue

• Incubate cells with RAN-2 Antibody (5 μg/ml) for 30 minutes at 4°C

• Wash cells to remove unbound antibody

• Incubate with anti-mouse IgG microbeads for 15 minutes at 4°C

• Wash cells and pass through magnetic separation column

• Collect both negative (flow-through) and positive (retained) fractions

• Expected yield: 90-95% purity of RAN-2-positive cells

Both methods can be validated by immunostaining a small aliquot of isolated cells to confirm enrichment of RAN-2-positive cells, with consideration that the isolated population will include astrocytes along with any other RAN-2-expressing cells present in the source tissue .

How can RAN-2 Antibody be incorporated into multi-color immunofluorescence protocols?

Designing effective multi-color immunofluorescence protocols with RAN-2 Antibody requires careful consideration of antibody compatibility and detection strategies:

Antibody Pairing Strategies:

• Same-species challenge: Since RAN-2 Antibody is mouse-derived, avoid other mouse antibodies or employ specialized techniques:

  • Sequential staining with directly conjugated antibodies

  • Use mouse IgG subclass-specific secondary antibodies (RAN-2 is IgG2)

  • Consider tyramide signal amplification for one marker before conventional staining

• Recommended combinations: Pair RAN-2 Antibody with rabbit, chicken, or goat-derived antibodies against complementary neural markers:

  • RAN-2 (mouse) + GFAP (rabbit) for astrocyte confirmation

  • RAN-2 (mouse) + AQP4 (rabbit) for astrocyte polarity studies

  • RAN-2 (mouse) + Iba1 (rabbit) to distinguish astrocytes from microglia

Fluorophore Selection Matrix:

Protocol Modifications for Multi-label Experiments:

• Increase blocking time to 2 hours with 10% normal serum from both secondary antibody species

• Include 0.2% Triton X-100 for consistent permeabilization

• Extend washing steps to 5× 10 minutes between antibody incubations

• Consider sequential staining for challenging combinations

• Image using sequential scanning on confocal microscopy to prevent bleed-through

These approaches enable researchers to effectively combine RAN-2 Antibody with other neural markers to investigate complex questions about astrocyte biology and interactions with other neural cell types .

How does RAN-2 Antibody compare with other astrocyte markers in developmental studies?

RAN-2 Antibody offers distinct advantages and limitations compared to other common astrocyte markers, particularly in developmental contexts:

Comparative Marker Analysis:

Developmental Research Applications:

• Temporal expression studies: RAN-2 can identify astrocyte-lineage cells before they express mature markers like GFAP

• Live cell sorting: As a surface marker, RAN-2 enables isolation of viable cells at different developmental stages

• Lineage tracing: RAN-2 can help distinguish astrocyte precursors from other neural progenitors in developing rat brain

Methodological Considerations:

• Combine RAN-2 with stage-specific markers (e.g., nestin, vimentin, GFAP) to precisely identify astrocyte developmental stages

• Use RAN-2 for surface labeling and other markers for internal structures to maximize information from each cell

• Consider regional variations in developmental timing when interpreting RAN-2 expression patterns

RAN-2 Antibody is particularly valuable for developmental studies requiring identification of astrocyte lineage cells before they express canonical markers, though researchers must account for its cross-reactivity with ependymal cells, Müller cells, and leptomeningeal cells when interpreting results .

What troubleshooting approaches are effective when RAN-2 Antibody staining yields unexpected results?

When encountering challenges with RAN-2 Antibody staining, researchers should employ a systematic troubleshooting approach:

Problem: Weak or Absent Signal

Problem: High Background or Non-specific Staining

Problem: Unexpected Cell Labeling Pattern

Systematic application of these troubleshooting approaches can help resolve most technical challenges encountered when working with RAN-2 Antibody in research applications .

What is the current understanding of the molecular function of the RAN-2 antigen in neural cells?

While RAN-2 Antibody has proven valuable as a cell-type specific marker, the molecular function of the RAN-2 antigen itself remains incompletely characterized. Current understanding suggests:

Structural Characteristics:

• The RAN-2 antigen is a cell surface protein expressed on specific rat neural cell types

• It is protease-sensitive, indicating protein composition is essential for antibody recognition

• The precise molecular weight and complete protein structure remain to be fully elucidated

Hypothesized Functional Roles:

• Cell-cell recognition: May facilitate specific interactions between astrocytes and other neural cells

• Extracellular matrix interaction: Could mediate attachment to specific ECM components

• Signaling receptor: Might participate in cell-specific signal transduction pathways

• Developmental regulation: Potentially involved in astrocyte differentiation or maturation

Experimental Evidence Gaps:

• The gene encoding RAN-2 has not been definitively identified

• Potential binding partners or ligands remain unknown

• Signal transduction pathways associated with RAN-2 require investigation

• Functional consequences of blocking RAN-2 with antibodies need further study

Research Approaches to Address Knowledge Gaps:

• Immunoprecipitation coupled with mass spectrometry to identify the antigen

• RNA-seq analysis comparing RAN-2 positive and negative cells to identify candidate genes

• CRISPR-based screens to identify the genetic basis of RAN-2 expression

• Functional assays examining effects of RAN-2 antibody on astrocyte behavior

Further molecular characterization of the RAN-2 antigen would enhance its utility beyond use as a cell-type marker, potentially revealing new insights into astrocyte biology and function .

How can RAN-2 Antibody be applied in neural tissue injury and regeneration studies?

RAN-2 Antibody offers several valuable applications in neural injury and regeneration research:

Experimental Applications in Injury Models:

• Astrocyte Reactivity Analysis:

  • Quantify changes in RAN-2 positive cell morphology after injury

  • Track proliferation of RAN-2 positive cells in response to injury

  • Compare RAN-2 expression with other reactive astrocyte markers

• Glial Scar Characterization:

  • Measure RAN-2 positive cell distribution within the glial scar

  • Analyze co-expression of RAN-2 with ECM components in scar tissue

  • Assess changes in RAN-2 expression during scar maturation and remodeling

• Cell Fate Tracking:

  • Monitor potential transdifferentiation of RAN-2 positive cells after injury

  • Assess migration of RAN-2 expressing cells into injury sites

  • Evaluate proliferative responses in different RAN-2 positive cell populations

Methodological Protocol for Time-Course Analysis:

• Establish rat neural injury model (e.g., cortical stab wound, spinal cord injury)

• Harvest tissue at defined intervals (1, 3, 7, 14, 28 days post-injury)

• Process for immunohistochemistry with standardized protocols

• Label with RAN-2 Antibody and complementary markers:

  • Ki67 or BrdU for proliferation

  • GFAP for reactive astrogliosis

  • Iba1 for microglial response

  • CSPGs for extracellular matrix deposition

• Quantify changes in:

  • Number of RAN-2 positive cells

  • Morphology of RAN-2 positive cells

  • Co-localization with other markers

  • Spatial distribution relative to injury site

This systematic approach can help researchers characterize the contribution of RAN-2 positive cells to injury response and recovery processes, potentially identifying new therapeutic targets for promoting neural repair .

What validation strategies should be employed when using RAN-2 Antibody in critical research applications?

Comprehensive validation of RAN-2 Antibody is essential for ensuring experimental rigor and reproducibility:

Multi-level Validation Framework:

• Specificity Validation:

  Validation Method	Protocol Elements	Expected Results
  Positive control tissues	Stain rat astrocyte cultures, brain sections	Clear membrane labeling of astrocytes, ependymal cells, Müller cells
  Negative control tissues	Stain non-rat tissues, rat neurons/oligodendrocytes	No specific labeling
  Antibody omission	Process tissue without primary antibody	No specific signal
  Isotype control	Use irrelevant mouse IgG2	No specific binding
  Peptide competition	Pre-incubate with immunizing peptide (if available)	Signal reduction or elimination

• Technical Validation:

  Validation Method	Protocol Elements	Expected Results
  Titration experiment	Test serial dilutions (1:10-1:1000)	Identification of optimal concentration
  Multiple detection methods	Test with different secondary antibodies/systems	Consistent pattern across methods
  Inter-lot comparison	Test multiple antibody lots	Consistent staining pattern
  Inter-lab reproducibility	Exchange protocols with collaborating labs	Consistent results across laboratories

• Molecular Validation:

  Validation Method	Protocol Elements	Expected Results
  Western blotting	Analyze rat brain/astrocyte lysates	Discrete band(s) of expected size
  Immunoprecipitation	Pull-down from rat brain lysate	Enrichment of specific protein(s)
  Mass spectrometry	Analyze immunoprecipitated proteins	Identification of specific antigen
  siRNA knockdown	Reduce expression in cultured cells	Diminished antibody signal

Documentation and Reporting Standards:

• Maintain detailed validation records including lot numbers, protocols, and images

• Include comprehensive validation data in publications as supplementary material

• Deposit validation data in public repositories when possible

• Document any lot-to-lot variation observed

Rigorous validation ensures that research findings based on RAN-2 Antibody labeling are reliable and interpretable, particularly when using this antibody for novel applications or critical decision-making in research .

How does RAN-2 compare with modern single-cell RNA-seq approaches for astrocyte identification?

As neuroscience research evolves, comparing traditional antibody-based approaches like RAN-2 immunolabeling with modern transcriptomic methods reveals complementary strengths and limitations:

Comparative Analysis of Methods:

Integrated Research Strategy:

• Complementary use cases:

  • Use RAN-2 for rapid identification/isolation of rat astrocytes in standard experiments

  • Employ scRNA-seq for discovery of novel astrocyte subtypes or states

  • Combine approaches to link transcriptional profiles with RAN-2-identified cells

• Validation workflow:

  • Identify marker genes in scRNA-seq data

  • Validate with RAN-2 and other protein markers by immunolabeling

  • Use RAN-2 to isolate populations for focused transcriptomic analysis

• Emerging spatial technologies:

  • Spatial transcriptomics provides gene expression data with spatial context

  • RAN-2 immunolabeling can help validate spatial transcriptomic findings

  • Combined approaches provide multimodal characterization of astrocytes

By understanding the relative advantages of RAN-2 Antibody and modern transcriptomic approaches, researchers can design more powerful experimental strategies that leverage the strengths of both methodologies to address complex questions in neural cell biology .